Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Palumbo, Antonio; Cavallo, Federica; Gay, Francesca; Di Raimondo, Francesco; Ben Yehuda, Dina; Teresa Petrucci, Maria; Pezzatti, Sara; Caravita, Tommaso; Cerrato, Chiara; Ribakovsky, Elena; Genuardi, Mariella; Maria Cafro, Anna; Marcatti, Magda; Catalano, Lucio; Offidani, Massimo; Michele Carella, Angelo; Zamagni, Elena; Patriarca, Francesca; Musto, Pellegrino; Evangelista, Andrea; Ciccone, Giovannino; Omedè, Paola; Crippa, Claudia; Corradini, Paolo; Nagler, Arnon; Boccadoro, Mario; Cavo, Michèle

doi:10.1056/nejmoa1402888

Public

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Published in New England Journal of Medicine • Sep 3, 2014

Authors:

Antonio Palumbo

Federica Cavallo

Francesca Gay

Abstract

BACKGROUND: This open-label, randomized, phase 3 study compared melphalan at a dose of 200 mg per square meter of body-surface area plus autologous stem-cell transplantation with melphalan-prednisone-lenalidomide (MPR) and compared lenalidomide maintenance therapy with no maintenance therapy in pati...

Subject

Medicine

Melphalan

Lenalidomide

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!